- idUS
- Listar por autor
Listar por autor "Valdés Delgado, Teresa"
Mostrando ítems 1-6 de 6
-
Artículo
Cut-off ranges of infliximab serum levels in Crohn’s disease in the clinical practice
Valdés Delgado, Teresa; Guerra Veloz, María Fernanda; Castro Laria, Luisa; Maldonado Pérez, Belén; Perea Amarillo, Raúl; Merino Bohórquez, Vicente; Sáez, Antonia; Caunedo Álvarez, Ángel; Argüelles Arias, Federico (Aran Ediciones S.A., 2020)Introduction: between 30 % and 40 % of patients treated with infliximab lose response during maintenance. Ther apeutic ...
-
Artículo
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
Guerra Veloz, María Fernanda; Belvis Jiménez, María Inmaculada; Valdés Delgado, Teresa; Castro Laria, Luisa; Maldonado Pérez, Belén; Perea Amarillo, Raúl; Merino Bohórquez, Vicente; Caunedo Álvarez, Ángel; Vilches Arenas, Ángel; Argüelles Arias, Federico (Original Research, 2019)Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated ...
-
Tesis Doctoral
Monitorización de niveles de Infliximab y anticuerpos Anti-Infliximab en pacientes con enfermedad inflamatoria intestinal en práctica clínica
Valdés Delgado, Teresa (2021-03-24)Introducción Infliximab (IFX) es un fármaco anti-TNF que consigue una buena tasa de respuesta y remisión en muchos ...
-
Artículo
Performance of a Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA
Valdés Delgado, Teresa; Aguado Paredes, Alicia; Merino Bohórquez, Vicente; Martín Manzanares, Jesús; Alonso, María Mercedes; Maldonado, Belén; Argüelles Arias, Federico (Springer, 2023-11-09)Background Therapeutic drug monitoring of infliximab levels in patients with inflammatory bowel disease (IBD) optimizes ...
-
Artículo
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
Guerra Veloz, María Fernanda; Vázquez Morón, Juan María; Belvis Jiménez, María Inmaculada; Pallares Manrique, Héctor; Valdés Delgado, Teresa; Castro Laria, Luisa; Merino Bohórquez, Vicente; Vilches Arenas, Ángel; Argüelles Arias, Federico (Aran Ediciones S.A., 2018)Background and aims: infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of ...
-
Artículo
Ustekinumab in Crohn’s disease: real-world outcomes and predictors of response
Lorenzo González, Laura; Valdés Delgado, Teresa; Vázquez Morón, Juan María; Castro Laria, Luisa; Leo Carnerero, Eduardo; Maldonado Pérez, María Belén; Sánchez Capilla, Damián; Pallarés Manrique, Héctor; Sáez Díaz, Antonia; Argüelles Arias, Federico (Aran Ediciones S.A., 2022)Background: ustekinumab is a monoclonal antibody that inhibits interleukins IL-12 and IL-23, and is approved for the ...